Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,000 | 201,000 | 222,000 | 238,000 | 248,000 |
| Marketable Securities | 552,000 | 621,000 | 759,000 | 593,000 | 663,000 |
| Receivables | 36,000 | 3,000 | 11,000 | 11,000 | 15,000 |
| TOTAL | $756,000 | $844,000 | $1,007,000 | $857,000 | $946,000 |
| Non-Current Assets | |||||
| PPE Net | 36,000 | 38,000 | 40,000 | 42,000 | 44,000 |
| Investments And Advances | 73,000 | 54,000 | 29,000 | 10,000 | 16,000 |
| Other Non-Current Assets | 59,000 | 61,000 | 63,000 | 65,000 | 69,000 |
| TOTAL | $168,000 | $153,000 | $132,000 | $117,000 | $129,000 |
| Total Assets | $924,000 | $997,000 | $1,139,000 | $974,000 | $1,075,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,000 | 39,000 | 42,000 | 42,000 | 29,000 |
| Other current liabilities | 145,000 | 136,000 | 154,000 | 141,000 | 110,000 |
| TOTAL | $198,000 | $209,000 | $231,000 | $235,000 | $210,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 101,000 | 100,000 | 99,000 | 98,000 | 97,000 |
| Deferred Revenues | 19,000 | 34,000 | 35,000 | 52,000 | 71,000 |
| Other Non-Current Liabilities | 124,000 | 119,000 | 135,000 | 152,000 | 159,000 |
| TOTAL | $262,000 | $264,000 | $277,000 | $303,000 | $316,000 |
| Total Liabilities | $460,000 | $473,000 | $508,000 | $538,000 | $526,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,333 | 125,773 | 125,350 | 107,974 | 106,431 |
| Common Shares | 2,169,000 | 2,138,000 | 2,116,000 | 1,815,000 | 1,793,000 |
| Retained earnings | -1,704,000 | -1,613,000 | -1,485,000 | -1,379,000 | -1,244,000 |
| Other shareholders' equity | -1,000 | -1,000 | 0 | 0 | 0 |
| TOTAL | $464,000 | $524,000 | $631,000 | $436,000 | $549,000 |
| Total Liabilities And Equity | $924,000 | $997,000 | $1,139,000 | $974,000 | $1,075,000 |